Comparison Between Physical Exercise and Alendronate Against Bone Calcium Levels and Body Weight In Wistar Rats Model Glucocorticoid-Induce Osteoporosis
DOI:
https://doi.org/10.22219/sm.Vol18.SMUMM1.21570Abstract
Glucocorticoid-induce osteoporosis (GIO) is a bone condition with osteoporosis due to taking long-term glucocorticoid drugs which is the most common cause of increasing the number of fracture cases which is a health problem. GIO is one of the most common forms of osteoporosis in men. Sodium alendronate is a biphosponate drug that is approved for prevention and management of GIO but has serious side effects on long-term use. Doing physical exercise "weight-bearing exercise" such as running is known to increase BMD (Bone Mineral Density) and can reduce osteoponia and the risk of osteoporosis. This study was a study with experimental studies, using male Wistar rats aged 8 weeks divided randomly into 4 groups, namely 1) positive control group (given oral prednisolone 0.54 mg/200g/day), 2) negative control group (not given oral prednisolone), 3) physical exercise group and 4) oral administration group of sodium alendronate (0.09 mg / 200g / day). Bone density will be measured by measuring the calcium level of the tibia bone using the AAS (Atomic Absorptions Spectrophotometer) method and the body weight of mice using scales. The results showed that physical exercise and sodium alendronate significantly affected p = 0.029 with (p <0.05) increasing calcium levels in rats induced by glucocorticoids and obtained p = 0.064 with (p <0.05) in this study there was no difference significant body weight difference between research groups
Downloads
References
Adachi J D, Papaioannou A. In whom and to prevent glucocorticoid-induced osteoporosis. Best Pract Res Clin Rheumatol. 2005; 19 (6): 1039-64.
Bonnet N , Ferrari L. Exercise and the skeleton: how it works and what it really does. IBMS BoneKey. 2010; 7 (7):235-48.
Davis S, Sachdeva A, Goeckeritz B, Oliver A. Approved treatments for osteoporosis and what’s in the pipeline. Consultantlive. 2010. Available from: http://www.consultantlive.com
De Vos P, Saladin R, Auwerx J, Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem. 1995;270:15958-61.
Fang j, DuBois DC, He Y, Almon RR, Jusko WJ. Dynamic modeling of methylprednisolone effects on body weight and glucose regulation in rats. J Pharmacokinet Pharmacodyn. 2011; 38(3): 293-316.
Iwamoto J, Yeh JK, Aloia JF. Differential effect of treadmill exercise on three cancellous bone sites in the young growing rat. Bone. 1999;24:163-69.
Lafage-Proust MH, Boudignon B, Thomas T. Glucocorticoid-induce osteoporosis: pathophysiological data and recent treatments. J Bone Spine. 2003; 70: 109-18.
Lloyd T, Petit A M, Hung-Mo L, Beck T J. Lifestyle factors and the development of bone mass and bone strength in young women. Jpeds. 2004;144 (6):776-82. Available from: http://dx.doi.org/10.1016/j.jpeds.2004.02.047.
Marques CMG, Lawford PV, Cochrane T. Effects of moderate exercise on biomechanical function of femur bones in wistar male rats [articel]. Sociedad Cubana de Bioingenieria. 2001. Available from: http: www.sld.cu/eventos/habana2001/arrepdf/00181.
Merck S & Dohme Corp. Medication guide fosamax (alendronate sodium) tablets. USA: Whitehouse Station: 2012. Available from: http://www.merck.com
Nurhadi FM. Pengaruh fat lose programme terhadap presentase lemak tubuh dan berat badan pada member fitness center gor UNY [Skripsi]. Fakultas Ilmu Keolahragaan UNY 2012.
Permadi A, Roeshadi D, Gunawan A. Studi komparasi efek pemberian raloxifen dan alendronate dalam menghambat penurunan kepadatan tulang pada terapi kortikosteroid jangka panjang tikus putih jantan (Rattus norvegicus). Majalah Orthopedi Indonesia 2007; xxxv (2): 80-98.
Permana Hikmat. Patomekanisme osteoporosis sekunder akibat steroid dan kondisi lainnya [mini review]. Bandung: Universitas Padjadjaran; 2013.
Sherwood L. Human physiology: from cells to systems, 6th edition. Jakata: Penerbit Buku Kedokteran EGC; 2011.
Shiga K, Hara H, Okano G, Ito M, Minami A, Tomita F. Ingestion of difructose anhydride III and volutary running exercise independently increase femoral and tibial bone mineral density and bone strength with increasing calcium absorption in rats. J Nutr 2003;133:4207-11.
Swenson K K, Nissen M J, Anderson E, Shapiro A, Schousboe J, Leach J. Effects of exercise vs bisphosponates on bone mineral density in breast cancer patients receiving chemotherapy. J Support Oncol. 2009; 7 (3): 101-07.
Ziegler R, Kasperk C. Glucocorticoid-induce osteoporosis: prevention and treatment. Steroids. 1998; 63:344-48.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Hanna Cakrawati, Minarma Siagian, Neng Tine Kartinah
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
